Actively Recruiting
Prospective Asian Multicenter Prostate Cancer Focal Therapy Study (ProAMFocal)
Led by Singapore General Hospital · Updated on 2024-07-08
500
Participants Needed
1
Research Sites
1304 weeks
Total Duration
On this page
Sponsors
S
Singapore General Hospital
Lead Sponsor
N
National Medical Research Council (NMRC), Singapore
Collaborating Sponsor
AI-Summary
What this Trial Is About
This is a multicenter observational study of patients undergoing focal therapy for prostate cancer in Asia
CONDITIONS
Official Title
Prospective Asian Multicenter Prostate Cancer Focal Therapy Study (ProAMFocal)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male patients diagnosed with prostate adenocarcinoma
- Maximum Gleason score of 4+4
- Cancer volume up to 1.5 ml with up to 2 lesions or up to 3 ml with a single lesion
- Prostate Specific Antigen (PSA) level of 15 ng/dl or less
- Clinical stage T2c or lower
- American Society of Anesthesiologist (ASA) score of 2 or less
You will not qualify if you...
- Evidence of extra-prostatic extension on multiparametric MRI, except capsular contact
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Singapore General Hospital
Singapore, Singapore, 169856
Actively Recruiting
Research Team
K
Kae Jack Tay, MBBS
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here